Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FBP1 | P09467 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL525220 | 0.85 | FBP1 (0.38) | FBP1 | |
| SCHEMBL7126113 | 0.85 | FBP1 (0.38) | FBP1 | |
| SCHEMBL11201007 | 0.83 | FBP1 (0.33) | FBP1 | |
| SCHEMBL5609915 | 0.81 | TSHR (0.33) | FBP1 | |
| SCHEMBL5609875 | 0.81 | FBP1 (0.32) | FBP1 | |
| SCHEMBL12667290 | 0.77 | FAAH (0.41) | — | |
| SCHEMBL5154971 | 0.76 | TDP1 (0.35) | — | |
| SCHEMBL3239691 | 0.74 | — | — | |
| SCHEMBL1333409 | 0.74 | — | — | |
| SCHEMBL3251574 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102241672-A | 2,3-dipyrrolyl-6-acylaminoquinoxaline compounds and preparation method thereof | UNIVTAISHAN MEDICAL | 2011-11-16 | — | — | CN | disclosed |
| WO-2007121853-A3 | LIGHTENING AND/OR COLOURING AGENTS COMPRISING N,N'-OXALYLDIAZOLES AND/OR OXIMIDYLDIAZOLES | HENKEL KGAA (DE) | 2007-12-21 | — | — | WO | disclosed |
| WO-2007121853-A2 | LIGHTENING AND/OR COLOURING AGENTS COMPRISING N,N'-OXALYLDIAZOLES AND/OR OXIMIDYLDIAZOLES | HENKEL AG & CO. KGAA (DE) | 2007-11-01 | — | — | WO | disclosed |
| WO-2007121853-A2 | LIGHTENING AND/OR COLOURING AGENTS COMPRISING N,N'-OXALYLDIAZOLES AND/OR OXIMIDYLDIAZOLES | HENKEL AG & CO. KGAA (DE) | 2007-11-01 | — | — | WO | disclosed |
| US-20030162960-A1 | Colormetric sensor compositions and methods | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-08-28 | — | — | US | disclosed |
| US-6482949-B1 | Colormetric sensor compositions and methods | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-11-19 | — | — | US | disclosed |
| US-5221680-A | Controlling or prevention of diseases of the cardiovascular system | CASSELLA AKTIENGESELLSCHAFT (DE) | 1993-06-22 | — | — | US | disclosed |
| EP-0429751-B1 | SUBSTITUTED 3-AMINO-SYDNONIMINES, PROCESS FOR THEIR PREPARATION AND THEIR USE | CASSELLA Aktiengesellschaft (DE) | 1993-06-16 | — | — | EP | disclosed |
| EP-0346694-B1 | SUBSTITUTED 3-AMINOSYDNONE IMINES, PROCESS FOR THEIR PREPARATION AND THEIR USE | CASSELLA Aktiengesellschaft (DE) | 1993-01-27 | — | — | EP | disclosed |
| US-5179206-A | Cardiovascular disorders; angina pectoris; hypotensive agents | CASSELLA AKTIENGELLSCHAFT (DE) | 1993-01-12 | — | — | US | disclosed |
| EP-0327808-B1 | SUBSTITUTED 3-AMINOSYDNONIMINES, PROCESS FOR THEIR PREPARATION AND THEIR USE | CASSELLA Aktiengesellschaft (DE) | 1991-05-02 | — | — | EP | disclosed |
| US-5006540-A | Cardiotonic agents | CASSELLA AKTIENGESELLSCHAFT (DE) | 1991-04-09 | — | — | US | disclosed |
| EP-0406659-A1 | Substituted 3-aminosydnonimines, process for their preparation and their use | CASSELLA Aktiengesellschaft (DE) | 1991-01-09 | — | — | EP | disclosed |
| EP-0406661-A1 | Substituted 3-aminosydnonimines, process for their preparation, and their use | CASSELLA Aktiengesellschaft (DE) | 1991-01-09 | — | — | EP | disclosed |
| US-4937244-A | HYPOTENSIVE AND CARDIOTONIC AGENTS; ANGINA PECTORIS | CASSELLA AKTIENGESELLSCHAFT (DE) | 1990-06-26 | — | — | US | disclosed |
| EP-0367036-A2 | Substituted 3-aminosydnonimines, process for their preparation and their use | CASSELLA Aktiengesellschaft (DE) | 1990-05-09 | — | — | EP | disclosed |
| EP-0346684-A1 | Substituted 3-aminosydnonimines, method for their preparation and their use | CASSELLA Aktiengesellschaft (DE) | 1989-12-20 | — | — | EP | disclosed |
| EP-0346694-A1 | Substituted 3-Aminosydnone imines, process for their preparation and their use | CASSELLA Aktiengesellschaft (DE) | 1989-12-20 | — | — | EP | disclosed |
| EP-0327808-A1 | Substituted 3-aminosydnonimines, process for their preparation and their use | CASSELLA Aktiengesellschaft (DE) | 1989-08-16 | — | — | EP | disclosed |
| EP-0312773-A2 | Substituted 3-aminosydnonimines, process for their preparation and their use | CASSELLA Aktiengesellschaft (DE) | 1989-04-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162960-A1 | Colormetric sensor compositions and methods | PAH, NISCH, SPR | FBP1 2602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.